Project Grant R01GM169394
- Federal Grant Award Summary Michigan State University received a $413,244 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 1, 2026, with completion targeted for May 31, 2031. The research focuses on developing catalyst-controlled methylene insertion reactions to streamline pharmaceutical synthesis. Specifically, the project aims to design iron-based catalytic systems that...
- Federal Grant Award Summary Michigan State University received a $335,924 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, through March 31, 2031. The award funds research to engineer glycyl radical enzyme (GRE) hydroalkylases for synthetic pharmaceutical applications. The project will develop biocatalytic methods to form new carbon-carbon bonds from simple starting...
- Federal Grant Award Summary The Dickson Lab at Michigan State University received a $593,975 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2026, with a completion date of March 31, 2031. The research focuses on developing advanced computational biophysics approaches to characterize protein-ligand interactions and advance drug discovery. The primary deliverables include the...
- Federal Project Grant Award Summary Michigan State University received an $809,743 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective August 10, 2025, with completion targeted for July 31, 2030. The project focuses on developing novel synthetic methodologies to produce homogeneous proteoglycan-like glycopeptides and glycoproteins bearing defined glycan structures. Recognizing that...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the Regents of the University of Michigan a $400,881 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) on February 26, 2026, with a completion date of December 31, 2030. This research initiative, titled "Uncovering Morphogenetic Modularity with Data Science," will deliver fundamental insights into tissue morphogenesis by investigating how cells organize...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the Regents of the University of Michigan a $565,993 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) effective June 1, 2026, with completion targeted for February 28, 2031. This award supports the development of next-generation native ion mobility-mass spectrometry (NIM-MS) methods for the structural characterization of biotherapeutics, including monoclonal...
- Federal Project Grant Award Summary Michigan State University (operating as Henry Ford Health + Michigan State University Health Sciences) received a $471,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 1, 2026, with completion targeted for April 30, 2031. The research project, "Mechanisms of Metal Receptors Controlling Inorganic Phenotypes," will deliver...
- Federal Grant Award Summary Michigan State University received a $633,240 Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences under the Biological Sciences program (CFDA 47.074), effective August 1, 2025, through July 31, 2029. This award supports the development of novel 1H-detected solid-state nuclear magnetic resonance (NMR) methodologies to characterize complex carbohydrate biopolymers in their native cellular environments. The research...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Michigan a Project Grant totaling $429,000 under the Biomedical Research and Research Training program (CFDA 93.859) on March 5, 2026, with completion scheduled for December 31, 2030. The research project investigates the mechanisms by which mammalian cells sense, respond to, and regulate inorganic phosphate (Pi) homeostasis in response to fluctuating extracellular phosphate levels....
- Federal Grant Award Summary The University of Michigan's Center for Structural Biology received a $430,143 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 15, 2026, with a completion date of June 14, 2027. The award funds the acquisition of an OCTET-RH16 System employing bio-layer interferometry (BLI) technology to measure real-time kinetics of biomolecular...
Michigan State University received a $294,266 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2026 through May 31, 2030. The award supports the development of mathematical and computational models to reconstruct high-resolution three-dimensional (3D) spatial genome architectures across diverse biological contexts, including different cell types, genotypes, and species. This research addresses a critical gap in genome analysis by moving beyond one-dimensional or two-dimensional approaches to characterize context-specific 3D genome structures with high resolution, which is essential for understanding how DNA folding orchestrates molecular biology and genetic processes. The project delivers advanced computational methodologies that will enable direct reconstruction of spatial genome structures in 3D space while managing the technical challenges inherent in Hi-C data profiling—particularly the high rates of missing data that complicate analysis across multiple biological contexts. The work is performed at Michigan State University's location in East Lansing, Michigan, and contributes to NIGMS's mission of supporting basic research that increases understanding of biological processes and provides foundational knowledge for advances in disease diagnosis, treatment, and prevention.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $294.3k | 7/16/26 |